Skip to content
MedsAcross

Medicine

Baclofen 15 mg tablet

Baclofen · Oral
Available on requestPrescription onlyUS FDAGeneric name

Baclofen 15 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68°to 77°F).

Key facts

Active ingredient (INN)
Baclofen
Brand
Sold under the generic name
Strength
15 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 1000 tablets, 500 tablets and 8 more
Manufacturers
Zydus LifesciencesIndiaAdvagen PharmaAsclemedTruPharma
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68°to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
M03BX01 Baclofen
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
5 February 2024
Identifiers
RxCUI 197391, 197392, 430902 +1DailyMed set ID 35bccefe-8d2e-85b5-e063-6394a90a58ca, 68aa591e-ea98-4438-9a4a-4f7e9ea2b285, 04dac0f6-cc6c-4959-9bca-a6e4a99690f3 +2NDC 76420-358, 52817-318, 72888-202 +2Application ANDA209102, ANDA211659

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle70710-1666-1Zydus LifesciencesIndia20 June 2024
100 tablet in 1 bottle70771-1868-1Zydus LifesciencesIndia20 June 2024
1000 tablet in 1 bottle72888-202-00Advagen Pharma5 February 2024
100 tablet in 1 bottle72888-202-01Advagen Pharma5 February 2024
500 tablet in 1 bottle72888-202-05Advagen Pharma5 February 2024
30 tablet in 1 bottle72888-202-30Advagen Pharma5 February 2024
100 tablet in 1 bottle52817-318-10TruPharma1 April 2024
100 tablet in 1 bottle76420-358-01Asclemed22 May 2025
30 tablet in 1 bottle76420-358-30Asclemed22 May 2025
60 tablet in 1 bottle76420-358-60Asclemed22 May 2025
90 tablet in 1 bottle76420-358-90Asclemed22 May 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 22 November 1977Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Baclofen

Clinical summary

Baclofen is a gamma-aminobutyric acid-ergic agonist indicated in the management of severe spasticity. It is available as tablets, injection and oral solution for intrathecal use. MedsAcross supplies Baclofen for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Baclofen

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Baclofen 15 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.